Literature DB >> 19967453

FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.

Nie Dongsong1, Jian Y Zhou.   

Abstract

Cyclin D1 is involved in regulating the transition of G1 to S-phase in the cell cycle through phosphorylation of the retinoblastoma susceptibility product (pRB). Amplification and overexpression of the cyclin D1 gene (CCND1) have been reported in human breast cancers and are suggested to play important roles in the pathogenesis of the disease process. Although cyclin D1 is potentially an important gene, relatively little is known about the distribution of its amplification in breast cancer cell lines. In this study, a cyclin D1 cosmid probe was isolated and used with fluorescence in situ hybridization (FISH) to identify the gene in chromosomal spreads of 12 breast cancer cell lines. Nine cell lines showed increased gene copy levels of cyclin D1, including Five cell lines had more than six copies of cyclin D1 on sister chromatids and four had more than four copies but less than six copies grouped at the chromosome 11 q13 band. Three cell lines had two "normal" chromosome 11 and one and two additional derivative chromosome 11's with three and four 11q13 sites which lacked amplification of cyclin D1 on any of these sites. Using progesterone receptor (PR) gene as an internal control, a 2.0-fold or greater increase in cyclin D1 gene signals, was observed in five of the ten cell lines by Southern hybridization, the Amplification level of cyclin D1 varied from 2.3 to 19.6-fold. Three cell lines with low amplification of cyclin D1 showed overexpression of the gene by Northern analysis. Our experiments demonstrated that FISH was more sensitive than Southern blot at demonstrating low levels of gene amplification and, additionally, permitted assessment of the distribution of cyclin D1 gene among chromosomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19967453     DOI: 10.1007/s11033-009-9939-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

Review 1.  Cyclin D1 in breast cancer pathogenesis.

Authors:  Andrew Arnold; Alexandros Papanikolaou
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

2.  Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.

Authors:  A B Gladden; R Woolery; P Aggarwal; M A Wasik; J A Diehl
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

3.  NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma.

Authors:  Leticia Quintanilla-Martinez; Stefania Pittaluga; Cornelius Miething; Margit Klier; Martina Rudelius; Theresa Davies-Hill; Natasa Anastasov; Antonio Martinez; Angelica Vivero; Justus Duyster; Elaine S Jaffe; Falko Fend; Mark Raffeld
Journal:  Blood       Date:  2006-05-18       Impact factor: 22.113

4.  Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.

Authors:  Xin Mao; Guy Orchard; Eric C Vonderheid; Peter C Nowell; Martine Bagot; Armand Bensussan; Robin Russell-Jones; Bryan D Young; Sean J Whittaker
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

5.  Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.

Authors:  Katja Specht; Marcus Kremer; Ulrike Müller; Stephan Dirnhofer; Michael Rosemann; Heinz Höfler; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

6.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.

Authors:  T C Wang; R D Cardiff; L Zukerberg; E Lees; A Arnold; E V Schmidt
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

7.  The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

8.  Overexpression of cyclin D1 enhances gene amplification.

Authors:  P Zhou; W Jiang; C M Weghorst; I B Weinstein
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

Review 9.  Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy.

Authors:  D Joshua Liao; Archana Thakur; Jack Wu; Hector Biliran; Fazlul H Sarkar
Journal:  Crit Rev Oncog       Date:  2007-11

10.  Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.

Authors:  L R Zukerberg; W I Yang; M Gadd; A D Thor; F C Koerner; E V Schmidt; A Arnold
Journal:  Mod Pathol       Date:  1995-06       Impact factor: 7.842

View more
  2 in total

1.  PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Authors:  Kazuya Shinmura; Nobuya Kurabe; Masanori Goto; Hidetaka Yamada; Hiroko Natsume; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.